These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3557886)

  • 1. Characterization of liposomes containing iodine-125-labeled radiographic contrast agents.
    Zalutsky MR; Noska MA; Seltzer SE
    Invest Radiol; 1987 Feb; 22(2):141-7. PubMed ID: 3557886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications.
    Seltzer SE; Davis MA; Adams DF; Shulkin PM; Landis WJ; Havron A
    Invest Radiol; 1984; 19(2):142-51. PubMed ID: 6533105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.
    Spataro RF; Fischer HW; Kormano M
    Invest Radiol; 1984; 19(6 Suppl):S372-5. PubMed ID: 6511276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diatrizoate, iopamidol, and ioxaglate for the contrast enhancement of experimental hepatic tumors in CT.
    Burgener FA; Steinmetz SD
    Invest Radiol; 1985 Sep; 20(6):626-31. PubMed ID: 4066232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of multilamellar liposomes containing 99mTcO4-: effect of distearoylphosphatidylcholine to sphingomyelin ratio.
    Zalutsky MR; Noska MA; Gallagher PW
    Int J Rad Appl Instrum B; 1986; 13(3):269-76. PubMed ID: 3021689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of liposomes as carriers for radiation synovectomy.
    Zalutsky MR; Noska MA; Gallagher PW; Shortkroff S; Sledge CB
    Int J Rad Appl Instrum B; 1988; 15(2):151-6. PubMed ID: 2835332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats.
    Ellens H; Morselt H; Scherphof G
    Biochim Biophys Acta; 1981 Apr; 674(1):10-8. PubMed ID: 7236723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress.
    Ryan PJ; Davis MA; DeGaeta LR; Woda B; Melchior DL
    Radiology; 1984 Sep; 152(3):759-62. PubMed ID: 6611564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of the brain by nonionic water soluble tri- and hexaiodinated contrast media. Experimental autoradiographic study of two contrast media: Iotrol and Iopamidol labelled with iodine 125.
    Castel JC; Dorcier F; Caillé JM
    Neuroradiology; 1987; 29(2):206-10. PubMed ID: 3587597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preparation and characterization of liposomes containing X-ray contrast agents.
    Ryan PJ; Davis MA; Melchior DL
    Biochim Biophys Acta; 1983 Mar; 756(1):106-10. PubMed ID: 6824745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhancement of the liver and blood. Nonionic versus ionic contrast media in the pig.
    Jensen LI; Golman K; Nyman U; Dean PB
    Invest Radiol; 1985 Dec; 20(9):989-94. PubMed ID: 4077451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
    Allen TM; Everest JM
    J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and clearance of contrast-carrying MREV liposomes.
    White C; Slifkin M; Seltzer SE; Blau M; Adzamli IK; Adams DF
    Invest Radiol; 1990 Oct; 25(10):1125-9. PubMed ID: 2079413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of 2,4,6,-triiodobenzoic derivatives with blood cells. I. Binding of 125I-labeled uropolin with lymphocytes and erythrocytes during separation of blood in uropolin-dextran gradient.
    Szymaniec S; Steuden W
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):793-5. PubMed ID: 999481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopaque liposomes: a promising new contrast material for computed tomography of the spleen.
    Havron A; Seltzer SE; Davis MA; Shulkin P
    Radiology; 1981 Aug; 140(2):507-11. PubMed ID: 7255729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics.
    Seltzer SE; Blau M; Herman LW; Hooshmand RL; Herman LA; Adams DF; Minchey SR; Janoff AS
    Radiology; 1995 Mar; 194(3):775-81. PubMed ID: 7862978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of a new arthrographic contrast agent: Iotrol.
    Guerra J; Resnick D; Haghighi P; Sovak M; Cone R
    Invest Radiol; 1984; 19(3):228-34. PubMed ID: 6469527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of intact liposomes of different compositions and of liposomal degradation products.
    Gotfredsen CF; Frøkjaer S; Hjorth EL; Jørgensen KD; Debroux-Guisset MC
    Biochem Pharmacol; 1983 Nov; 32(22):3381-7. PubMed ID: 6651862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy.
    Derksen JT; Baldeschwieler JD; Scherphof GL
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9768-72. PubMed ID: 3200855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrizamide in experimental urography. V. Renal excretion mechanism of a non-ionic contrast medium in rabbit and cat.
    Golman K; Scient C
    Invest Radiol; 1976; 11(3):187-94. PubMed ID: 939675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.